Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H5AsO5 |
| Molecular Weight | 183.9797 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C[As](O)(O)=O
InChI
InChIKey=SIYRQHPXBLWQRE-UHFFFAOYSA-N
InChI=1S/C2H5AsO5/c4-2(5)1-3(6,7)8/h1H2,(H,4,5)(H2,6,7,8)
| Molecular Formula | C2H5AsO5 |
| Molecular Weight | 183.9797 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://pubchem.ncbi.nlm.nih.gov/compound/67177Sullivan, R.J. (1969) 'AIR POLLUTION ASPECTS OF ARSENIC AND ITS COMPOUNDS', p.60 Retrieved from https://yosemite.epa.gov/oa/EAB_Web_Docket.nsf/Attachments%20By%20ParentFilingId/3B14C316D06D4BCE85257F40006A588B//NAPCA%201969.pdfCurator's Comment: description was created based on several sources, including:
Wilson, P.S. (2009) "Rediscovering Arsenoacetic Acid", p.9 Retrieved from http://researchcommons.waikato.ac.nz/bitstream/handle/10289/2778/thesis.pdf?sequence=1
Sources: https://pubchem.ncbi.nlm.nih.gov/compound/67177Sullivan, R.J. (1969) 'AIR POLLUTION ASPECTS OF ARSENIC AND ITS COMPOUNDS', p.60 Retrieved from https://yosemite.epa.gov/oa/EAB_Web_Docket.nsf/Attachments%20By%20ParentFilingId/3B14C316D06D4BCE85257F40006A588B//NAPCA%201969.pdf
Curator's Comment: description was created based on several sources, including:
Wilson, P.S. (2009) "Rediscovering Arsenoacetic Acid", p.9 Retrieved from http://researchcommons.waikato.ac.nz/bitstream/handle/10289/2778/thesis.pdf?sequence=1
Disodiurn salt of Arsonoacetic acid has been used in veterinary to treat anaplasmosis (babesiasis); as general stimulant in nervous disease; for eclampsia of bitches, and with adjuncts in chronic eczema and follicular mange. Arsonoacetic acid has not featured much in human medicine, a Chinese patent however, was filed in 2003 for arsonoacetic acid and its methyl or ethyl derivatives as chemotherapeutic drugs again liver cancer.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2364672 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6083781 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | MERICYL Approved UseRoborant and general tonic (nutritional supplements) |
|||
| Inactive ingredient | AMERFRESH Approved UseAids in the prevention of dental cavities |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Tumor cell-specific prodrugs using arsonic acid-presenting iron oxide nanoparticles with high sensitivity. | 2012-08-01 |
|
| Arsonic acid-presenting superparamagnetic iron oxide for pH-responsive aggregation under slightly acidic conditions. | 2011-04-01 |
|
| The construction of a whole-cell biosensor for phosphonoacetate, based on the LysR-like transcriptional regulator PhnR from Pseudomonas fluorescens 23F. | 2009-03 |
|
| Carbon-arsenic bond cleavage by a newly isolated gram-negative bacterium, strain ASV2. | 1995-03 |
|
| The mechanism of pyrophosphorolysis of RNA by RNA polymerase. Endowment of RNA polymerase with artificial exonuclease activity. | 1984-12-01 |
|
| Mode of action of phosphonoformate as an anti-herpes simplex virus agent. | 1981-01-29 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://starlabs-pk.business1.com/products/mericyl-injection.html http://starlabs.com.pk/mericyl-injection.html
Curator's Comment: Veterinary drug
Horses, Cattle 10 ml
Sheep, Goats 2-5 ml
Big dogs 1.2 ml
Dogs, Cats 0.2-0.5 ml
Each ml contains 50 mg of disodium arsonoacetate.
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:05:22 GMT 2025
by
admin
on
Mon Mar 31 21:05:22 GMT 2025
|
| Record UNII |
HLD4YD798I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
HLD4YD798I
Created by
admin on Mon Mar 31 21:05:22 GMT 2025 , Edited by admin on Mon Mar 31 21:05:22 GMT 2025
|
PRIMARY | |||
|
67178
Created by
admin on Mon Mar 31 21:05:22 GMT 2025 , Edited by admin on Mon Mar 31 21:05:22 GMT 2025
|
PRIMARY | |||
|
DTXSID00861774
Created by
admin on Mon Mar 31 21:05:22 GMT 2025 , Edited by admin on Mon Mar 31 21:05:22 GMT 2025
|
PRIMARY | |||
|
12603
Created by
admin on Mon Mar 31 21:05:22 GMT 2025 , Edited by admin on Mon Mar 31 21:05:22 GMT 2025
|
PRIMARY | |||
|
28506
Created by
admin on Mon Mar 31 21:05:22 GMT 2025 , Edited by admin on Mon Mar 31 21:05:22 GMT 2025
|
PRIMARY | |||
|
107-38-0
Created by
admin on Mon Mar 31 21:05:22 GMT 2025 , Edited by admin on Mon Mar 31 21:05:22 GMT 2025
|
PRIMARY | |||
|
m2070
Created by
admin on Mon Mar 31 21:05:22 GMT 2025 , Edited by admin on Mon Mar 31 21:05:22 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |